Menu
Recruiting NCT04313140

Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

No phase Interventional Development of the Virtual Biopsy Tumor Grade Artificial Intelligence Algorithms Clinical

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Diagnostic test.
Who it may be relevant to
Registry conditions: Development of the Virtual Biopsy, Tumor Grade, Artificial Intelligence Algorithms, Clinical. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Glioma is a tumor of the central nervous system. These lesions are sorted with the WHO ranking regarding the tumoral oncotype. The tumoral MRI assessment is the first step before any medical decision. Currently, only anatomical biopsy can give the tumor grade definition and help to define the most adapted treatment.

Interventions

  • Diagnostic test Diagnostic test
    The intervention occurs only one time (for 2h30), the MRI examination is divided as follow: * Cinicial MRI (50 minutes) * Research MRI (Phosphorus Spectroscopy, Sodium Imaging)

Primary outcome measures

  • Validation of the virtual biopsy in the context of gliomas through the use of statistical learning algorithms (artificial intelligence) compared to the biopsy. [Time frame: The MRI examination (for 2 hours 30 minutes)]

Eligibility criteria

Inclusion criteria

  • Age≥ 18 years,
  • Patient with suspected glioma with prior imaging
  • Subject free, with legal protection guardianship or curatorship;
  • Enrollment in the French Social Security system;
  • Informed consent signed by the patient

Exclusion criteria

  • Any contraindication to an MRI examination
  • Legal protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, persons residing in a health or social establishment, adults under legal protection and finally patients in emergency situations
  • Pregnant or lactating women, women of childbearing age who do not have effective contraception

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Diagnostic

Study locations

France · 1 center
  • CHU De Poitiers — Poitiers

Identifiers

NCT: NCT04313140 · 2019-A02531-56

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗